Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 17.75 INR
Change Today -1.35 / -7.07%
Volume 881.0
As of 6:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

resonance specialties ltd (RES) Snapshot

Open
15.05
Previous Close
19.10
Day High
19.20
Day Low
15.05
52 Week High
09/12/14 - 27.50
52 Week Low
03/27/15 - 13.00
Market Cap
204.9M
Average Volume 10 Days
1.1K
EPS TTM
1.11
Shares Outstanding
11.5M
EX-Date
09/15/15
P/E TM
16.0x
Dividend
0.50
Dividend Yield
--
Current Stock Chart for RESONANCE SPECIALTIES LTD (RES)

Related News

No related news articles were found.

resonance specialties ltd (RES) Related Businessweek News

No Related Businessweek News Found

resonance specialties ltd (RES) Details

Resonance Specialties Limited manufactures and sells pyridines and its derivatives in India. Its products comprise pyridine, a chemical used in the manufacture of agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; picolines, including alpha picoline used in the vinyl latex rubber, beta picoline used in the manufacture of vitamin B3, and gamma picoline used for the manufacture of anti-tuberculosis drugs; and cyanopyridines that are used in the manufacture of Vitamin B3 and anti-tuberculosis drugs. The company’s drug intermediates and active pharmaceutical ingredients include nutritional products, such as zinc picolinate, chromium picolinate, chromium polynicotinate, niacin, and niacinamide; anti-tuberculosis products, including isoniazid; and drug intermediates comprising picolinic and dipicolinic acids. In addition, it offers lutidines for use in anti-ulcer drugs, including omeprazol, lansaprazole, and rebaprazole; and collidine that is used in the manufacture of omeprazole and vitamin D3. Resonance Specialties Limited exports its products worldwide through supply agreements with various multinationals, as well as through direct exports. The company, formerly known as Armour Polymers Limited, was incorporated in 1989 and is headquartered in Mumbai, India.

Founded in 1989

resonance specialties ltd (RES) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 2.9M
Whole-Time Director
Total Annual Compensation: 893.3K
Compensation as of Fiscal Year 2014.

resonance specialties ltd (RES) Key Developments

Resonance Specialties Limited Announces Board Appointments

Resonance Specialties Limited announced that its Board of Directors at its meeting, held on August 06, 2015, regularized the appointment of Dr. Gurpur Ganesh Pai and Ms. Urvi A. Gupta as Directors of the company, subject to approval of Members at the Annual General Meeting of the company.

Resonance Specialties Limited, Board Meeting, Aug 06, 2015

Resonance Specialties Limited, Board Meeting, Aug 06, 2015. Agenda: To recommend, consider and adopt the audited Balance Sheet as at March 31, 2015, the profit and loss account for the year ended on that date and the report of the Board of Directors and auditors thereon to members; to re-appoint Mr. B. P. Agrawal, who retires by rotation and being eligible, offers himself for re-appointment; to ratify the appointment of M/s. V. R. Bhabhara & Co., Chartered Accountant as Statutory Auditors of the company; to regularize the appointment of Mr. Gurpur Ganesh Pai and Ms. Urvi A. Gupta as a Directors of the company; to re-appoint Dr. A. B. Gupta whose term of appointment as a Managing Director of the company will expire on August 31, 2015; to adopt new set of Article of Association of the company containing regulation in conformity with the companies Act, 2013; to consider and fix the dates for the closing of Register of Members and Transfer Books; and to consider and fix day, date, time and venue and approve draft of Notice for 26th AGM of the company.

Resonance Specialties Limited to Report Q1, 2016 Results on Aug 06, 2015

Resonance Specialties Limited announced that they will report Q1, 2016 results on Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RES:IN 17.75 INR -1.35

RES Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RES.
View Industry Companies
 

Industry Analysis

RES

Industry Average

Valuation RES Industry Range
Price/Earnings 29.2x
Price/Sales 0.6x
Price/Book 1.1x
Price/Cash Flow 11.6x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESONANCE SPECIALTIES LTD, please visit www.resonancesl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.